Brooks Laboratories Limited

Brooks Laboratories Limited (BROOKS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

brookslabs.net(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹64.15
Market cap
188 Cr
Stock P/E
17.5
P/B
1.50

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales24 Cr22 Cr18 Cr18 Cr21 Cr21 Cr23 Cr26 Cr23 Cr17 Cr20 Cr23 Cr
Operating expenses (approx.)23 Cr21 Cr17 Cr18 Cr19 Cr19 Cr22 Cr22 Cr21 Cr16 Cr20 Cr21 Cr
EBITDA2 Cr1 Cr0.38 Cr0.28 Cr2 Cr2 Cr2 Cr3 Cr3 Cr0.73 Cr0.68 Cr2 Cr
OPM %7.1%5.0%2.1%1.6%7.3%7.7%6.6%12.3%10.8%4.4%3.4%8.1%
Other income0.09 Cr0.15 Cr0.65 Cr0.07 Cr0.20 Cr0.03 Cr0.62 Cr0.22 Cr0.39 Cr0.13 Cr0.44 Cr0.18 Cr
Interest0.19 Cr0.21 Cr0.27 Cr0.16 Cr0.32 Cr0.28 Cr0.26 Cr0.30 Cr0.28 Cr0.16 Cr0.09 Cr0.21 Cr
Depreciation0.44 Cr0.43 Cr0.46 Cr0.40 Cr0.43 Cr0.38 Cr0.39 Cr0.39 Cr0.39 Cr0.39 Cr0.41 Cr0.42 Cr
Profit before tax-2 Cr-4 Cr-10 Cr-2 Cr-4 Cr-2 Cr-1 Cr10 Cr8 Cr5 Cr2 Cr-2 Cr
Tax %0.0%-0.7%0.0%0.0%0.0%0.0%-13.7%0.0%0.0%0.0%0.0%0.0%
Net profit-2 Cr-4 Cr-10 Cr-2 Cr-4 Cr-2 Cr-1 Cr10 Cr8 Cr5 Cr2 Cr-2 Cr
EPS (₹)₹-0.64₹-1.51₹-3.77₹-0.94₹-1.51₹-0.82₹-0.54₹3.25₹2.71₹1.87₹0.52₹-0.61

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales77 Cr91 Cr63 Cr79 Cr83 Cr86 CrSign in for TTM
Operating expenses (approx.)77 Cr105 Cr90 Cr76 Cr78 Cr79 CrSign in for TTM
EBITDA0.52 Cr-14 Cr-26 Cr3 Cr5 Cr7 CrSign in for TTM
OPM %0.7%-15.8%-41.8%4.0%6.0%8.2%Sign in for TTM
Other income0.74 Cr0.91 Cr0.20 Cr0.96 Cr0.88 Cr1 CrSign in for TTM
Interest3 Cr3 Cr2 Cr0.84 Cr1 Cr0.84 CrSign in for TTM
Depreciation7 Cr7 Cr7 Cr2 Cr2 Cr2 CrSign in for TTM
Profit before tax-9 Cr-24 Cr-39 Cr2 Cr-10 Cr25 CrSign in for TTM
Tax %-115.4%19.2%18.7%1.7%-1.8%0.0%Sign in for TTM
Net profit-19 Cr-19 Cr-32 Cr-20 Cr-10 Cr25 CrSign in for TTM
EPS (₹)₹6.31₹-7.82₹-12.57₹-7.67₹-3.72₹8.35Sign in for TTM
Dividend payout %—————0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital25 Cr25 Cr25 Cr26 Cr29 Cr29 Cr
Reserves54 Cr54 Cr49 Cr39 Cr69 Cr93 Cr
Borrowings31 Cr24 Cr6 Cr5 Cr6 Cr7 Cr
Other liabilities52 Cr37 Cr30 Cr20 Cr20 Cr18 Cr
Total liabilities162 Cr196 Cr110 Cr90 Cr124 Cr148 Cr
Fixed assets (net)107 Cr108 Cr14 Cr13 Cr13 Cr13 Cr
CWIP0.68 Cr15 Cr0 Cr0 Cr1 Cr1 Cr
Investments0.02 Cr0.06 Cr64 Cr43 Cr74 Cr92 Cr
Loans & advances0.44 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Inventories24 Cr28 Cr11 Cr10 Cr9 Cr11 Cr
Trade receivables14 Cr18 Cr13 Cr16 Cr20 Cr16 Cr
Cash & bank0.88 Cr3 Cr0.02 Cr0.13 Cr0.04 Cr7 Cr
Other assets16 Cr25 Cr7 Cr8 Cr7 Cr8 Cr
Total assets162 Cr196 Cr110 Cr90 Cr124 Cr148 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity—-37 Cr-14 Cr-10 Cr3 Cr9 Cr
Cash from investing—-25 Cr0.49 Cr0.18 Cr-46 Cr-3 Cr
Cash from financing—64 Cr11 Cr10 Cr43 Cr0.17 Cr
Net cash flow—2 Cr-3 Cr0.10 Cr-0.08 Cr7 Cr
Free cash flow (OCF − Capex)—-65 Cr-15 Cr-10 Cr2 Cr6 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %-5.3%-26.3%-46.4%3.4%-8.4%19.6%
ROE %-24.5%-20.5%-28.3%-29.9%-10.2%20.0%
Debtor days657173758868
Inventory days18415999787181
Days payable24116220512610584
Cash conversion cycle768-32275465
Debt / equity0.390.380.080.080.060.06
Current ratio0.751.250.841.351.481.72
Net debt / EBITDA0.00——1.531.220.10

Compare with peers

Loading peers…